Related Experiment Video

Updated: Jul 19, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[First National Consensus on Chronic Hepatitis B]

Eduardo R Marín López1,

  • 1Servicio de Gastroenterología del Hospital de la Beneficencia Española de Puebla, Puebla, Pue. e_marin@prodigy.net.mx

Revista De Gastroenterologia De Mexico
|October 25, 2006
PubMed

Insights

Mexican experts created the First National Consensus on Chronic Hepatitis B, integrating new diagnostics and antivirals for improved patient management and high-risk group approaches. This consensus aims to simplify complex aspects of Hepatitis B care.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Chronic Hepatitis B (CHB) remains a significant public health concern globally and in Mexico.
  • Advances in diagnostics, antivirals, and immunoprophylaxis necessitate updated clinical guidelines.
  • Previous lack of a unified national consensus hindered optimal CHB management in Mexico.

Framework:

  • The First National Consensus on Chronic Hepatitis B convened 34 leading Mexican experts in Hepatology, Gastroenterology, Infectology, Pediatrics, Oncology, Pathology, and Molecular Biology.
  • The consensus aimed to synthesize current knowledge and establish evidence-based recommendations for CHB.
  • Discussions focused on integrating new diagnostic methods, understanding disease natural history, and applying novel therapeutic agents.

Implementation:

  • The consensus addresses the practical application of sensitive diagnostic methods for HBV infection.
  • It provides guidance on the appropriate use of passive and active immunoprophilaxis strategies.
  • Recommendations cover the management of infected patients, including the use and indications for new antiviral therapies.

Implications:

  • This consensus provides a foundational framework for improving the clinical practice of CHB management in Mexico.
  • It aims to demystify complex aspects of Hepatitis B, including molecular biology and serologic markers.
  • The initiative is expected to enhance the approach to high-risk populations and optimize patient outcomes through standardized care.

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...